tirzepatide or semaglutide for pcos Women with seek relief in weight-loss drugs Managing PCOS with tirzepatide on

Opportunities Outside of Diabetes and Obesity Additional Indications for Exploration Additional Indications for Exploration As new companies look to enter the incretin mimetic space, and existing players seek to expand their portfolios, its increasingly important to look beyond diabetes and obesity

It involves recognizing how your body's appetite signals change, ensuring adequate nutrient intake despite reduced volume, and working with a healthcare provider to establish sustainable eating patterns that support long-term metabolic health

Semaglutide commonly causes nausea, bloating, or constipation as the body adjusts to slower digestion

This one closes the loop: these drugs are not the end of anything